Serological response 5 months after the BNT162b2 COVID-19 vaccination in patients with various hematological disorders in Japan

PURPOSE: Patients with hematological malignancies are at an increased risk of severe infection with coronavirus disease 2019 (COVID-19). However, developing an adequate immune response after vaccination is difficult, especially in patients with lymphoid neoplasms. Since the long-term effects of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Marumo, Yoshiaki, Yoshida, Takashi, Furukawa, Yuki, Ina, Kenji, Kamiya, Ayumi, Kataoka, Takae, Kayukawa, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655153/
https://www.ncbi.nlm.nih.gov/pubmed/38025915
http://dx.doi.org/10.7774/cevr.2023.12.4.319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655153/
https://www.ncbi.nlm.nih.gov/pubmed/38025915
http://dx.doi.org/10.7774/cevr.2023.12.4.319

Ejemplares similares